scispace - formally typeset
R

Ramesh Rengan

Researcher at University of Washington

Publications -  97
Citations -  3541

Ramesh Rengan is an academic researcher from University of Washington. The author has contributed to research in topics: Radiation therapy & Lung cancer. The author has an hindex of 20, co-authored 89 publications receiving 2778 citations. Previous affiliations of Ramesh Rengan include University of Washington Medical Center & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

TL;DR: Major tumour regressions are reported in a subset of patients with metastatic melanoma treated with an anti-CTLA4 antibody and radiation and reproduced this effect in mouse models, showing that PD-L1 on melanoma cells allows tumours to escape anti- NCTLA4-based therapy, and the combination of radiation, anti- CTLA4 and anti-PD-L 1 promotes response and immunity through distinct mechanisms.
Journal ArticleDOI

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.

TL;DR: This joint ESTRO-ASTRO practice recommendation established pragmatic and balanced consensus recommendations in common clinical scenarios of radiotherapy for lung cancer in order to address the challenges of the COVID-19 pandemic.
Journal ArticleDOI

A moving target: Image guidance for stereotactic body radiation therapy for early-stage non-small cell lung cancer

TL;DR: Kovoltage x-ray matching to bony anatomy is inadequate for accurate positioning when a conventional 3-5 mm margin is employed prior to lung SBRT, and CBCT image guidance with a 5-mm planning target volume margin is recommended.
Journal ArticleDOI

Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study.

TL;DR: The results of this study provide population-based estimates for the incidence rates of patients with bone metastases at initial diagnosis of their solid tumor and can help clinicians to early detectBone metastases by bone screening to anticipate the occurrence of symptoms and favorably improve the prognosis.